France · Question · Question écrite
8612
Question 8612 — pharmacy and medicines
Introduced
15 July 2025
Last action
15 July 2025 · Question
Status
posée
Sponsors
—
Subjects
Discovery layer
Source updated
15 July 2025
Summary
Mr. Julien Gokel draws the attention of the Minister to the Minister of Labor, Health, Solidarity and Families, responsible for health and access to care, to the consequences of the reduction in commercial discounts on generic, biosimilar and hybrid medicines. This measure, decided without consultation with the profession, comes in a context of deterioration in health insurance accounts and aims to compensate exceeding the national health insurance objective (ONDAM) for 2025. It arouses great concern among pharmacists, who warn of its deleterious effects on the economic viability of the pharmacy network. For more than twenty years, commercial discounts on generics have ensured a fragile, but essential, balance between controlling health care costs and equitable access to medicines. By weakening this model, the Government risks putting many pharmacies in difficulty, particularly in rural and peri-urban areas, and encouraging the emergence of pharmaceutical deserts. This situation would be detrimental to equal access to care, as well as to the public health missions currently carried out by pharmacists (prevention, vaccination, screening or support for chronic patients, etc.). Furthermore, this ad hoc and brutal measure masks the absence of structural reform. The Government did not initiate, as planned, negotiations with pharmaceutical laboratories with a view to lowering prices, which would have made it possible to avoid such unilateral decisions taken in an emergency. Consequently, he asks the Government if it intends to suspend this measure and quickly open a global consultation with stakeholders in the sector, in order to to identify fairer levers to control health spending, while guaranteeing the sustainability of the pharmacy network and encouraging the development of the dispensation of generic and biosimilar medicines.
Machine translation from French. The official text remains authoritative.
Timeline
15 July 2025
Question
Source: DateQuestion
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- Julien Gokel · auteur
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/17/questions/QANR5L17QE8612
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L17QE8612
- france · QANR5L17QE8612 · source updated 15 July 2025